U.S. Thrombectomy Devices Market Top Key Players: Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Penumbra, Inc., Koninklijke Philips N.V., AngioDynamics, Inc., Terumo Corporation

A fresh report titled “U.S. Thrombectomy Devices Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for U.S. Thrombectomy Devices Market. The competition analysis is also a major part of the report.

Thrombectomy is the surgical removal of blood clot from a blood vessel. Deep vein thrombosis is a life-threatening disease where blood clots within a vein. These clots can pass through to arteries or veins in different body parts—brain, heart, kidneys, lungs, and limbs. Similarly, venous thromboembolism (VTE) is considered as the cause of heart attack and stroke; however, it can damage body organs or may even lead to death. VTE results due to various factors such as combination of hereditary and acquired risk factors. It can be diagnosed in smoking population and people who consume estrogens or birth control pills. VTE is highly prevalent in adults (>60 years), however, can occur at any age.

Request for Sample @ https://www.kdmarketinsights.com/sample/3403

The U.S. thrombectomy devices market is was valued at $501.9 million in 2017, and is estimated to garner $750.4 million by 2025, registering a significant CAGR of 5.1% from 2018 to 2025. This is attributed to increase in incidence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE), due to sedentary lifestyle and unhealthy living conditions & habits along with rise in geriatric population in the U.S. Moreover, increase in incidence of cardiovascular diseases, surge in demand for minimally invasive procedures, rise in need for sophisticated healthcare infrastructure; and increase in market competition have led to technological advancements and innovations. However, lack of trained professionals & awareness and complicated use of these devices restrict the market growth. On the contrary, introduction of lasers & UV radiation and 3D imaging generation in thrombectomy devices is anticipated to provide lucrative growth opportunities to market players in the near future.

The U.S. thrombectomy devices market is segmented based on technology, type, utility, and disease. Depending on the type of technology, the market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. By type, it is bifurcated into automated and manual thrombectomy devices. As per utility, it is classified into reusable and disposable thrombectomy devices. On the basis of disease, it is divided into peripheral, neurovascular, and coronary thrombectomy devices.

Key Benefits for U.S. Thrombectomy Devices Market:

– The U.S. thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.
– The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
– The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 2018–2025.
– Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.

U.S. Thrombectomy Devices Key Market Segments:

By Technology
– Mechanical Thrombectomy Devices
– Aspiration Thrombectomy Devices
– Rheolytic Thrombectomy Devices

By Type
– Automated Thrombectomy Devices
– Manual Thrombectomy Devices

By Disease
– Peripheral Thrombectomy Devices
– Coronary Thrombectomy Devices
– Neural Thrombectomy Devices

By Utility
– Reusable Thrombectomy Devices
– Disposable Thrombectomy Devices

Key Market Players
– Boston Scientific Corporation
– Medtronic plc
– Teleflex Incorporated
– Penumbra, Inc.
– Koninklijke Philips N.V.
– AngioDynamics, Inc.
– Terumo Corporation
– Johnson and Johnson
– Stryker Corporation
– Capture Vascular, Inc.

The other players in the value chain include (profiles not included in the report)
– Argon Medical Devices, Inc.
– Inari Medical, Inc.

Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/us-thrombectomy-devices-market-amr

Table of Content

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
3.5.1.2. Surge in demand for minimally invasive procedures
3.5.1.3. Technological advancements & innovations

3.5.2. Restraints

3.5.2.1. High cost and complications associated with the use of thrombectomy devices
3.5.2.2. Dearth of trained professionals & lack of awareness

3.5.3. Opportunities

3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2. Combination of decompressive surgery and thrombectomy

CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY

4.1. Overview

4.1.1. Market size and forecast

4.2. Mechanical thrombectomy devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Aspiration thrombectomy devices

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Rheolytic thrombectomy devices

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Automated thrombectomy devices

5.2.1. Market size and forecast

5.3. Manual thrombectomy devices

5.3.1. Market size and forecast

CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE

6.1. Overview

6.1.1. Market size and forecast

6.2. Neurovascular thrombectomy devices

6.2.1. Market size and forecast

6.3. Peripheral thrombectomy devices

6.3.1. Market size and forecast

6.4. Coronary thrombectomy devices

6.4.1. Market size and forecast

CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY

7.1. Overview

7.1.1. Market size and forecast

7.2. Reusable thrombectomy devices

7.2.1. Market size and forecast

7.3. Disposable thrombectomy devices

7.3.1. Market size and forecast

Continue…

Check for Discount @ https://www.kdmarketinsights.com/discount/3403

Contact Us

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com

About KD Market Insights

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

This release was published on openPR.